The trademark application GutAlive was filed by Microviable Therapeutics, a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on May 20, 2021, and it was registered by office on August 27, 2021 without any oppositions.
The application was filed in Spanish (English was selected as the second language).